Quick Answer
Korro Bio, Inc. reported Shares Outstanding of 9.42 million shares for fiscal year 2025.
Korro Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 9.42M | +0.4% |
| 2024 | 9.38M | +17.0% |
| 2023 | 8.02M | +2886.0% |
| 2022 | 268,468 | -99.2% |
| 2021 | 34.61M | +1.9% |
| 2020 | 33.96M | +10.1% |
| 2019 | 30.84M | +1379.6% |
| 2018 | 2.08M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 9.40M | +0.9% | +0.1% |
| June 30, 2025 | 9.39M | +1.2% | +0.0% |
| March 31, 2025 | 9.39M | +17.0% | +0.1% |
| December 31, 2024 | 9.38M | +17.0% | +0.6% |
| September 30, 2024 | 9.32M | -74.8% | +0.4% |
| June 30, 2024 | 9.28M | -74.2% | +15.7% |
| March 31, 2024 | 8.02M | -77.6% | +0.1% |
| December 31, 2023 | 8.02M | -77.3% | -78.3% |
- Korro Bio, Inc. showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Korro Bio, Inc.’s shares outstanding has grown by 351.7% (from 2.08 million shares to 9.42 million shares).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: